GURUFOCUS.COM » STOCK LIST » Asia » China » SHSE » Novogene Co Ltd (SHSE:688315) » Definitions » Price-to-Free-Cash-Flow
Switch to:

Novogene Co (SHSE:688315) Price-to-Free-Cash-Flow

: 78.25 (As of Today)
View and export this data going back to 2021. Start your Free Trial

As of today (2023-03-21), Novogene Co's share price is ¥29.11. Novogene Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2022 was ¥0.37. Hence, Novogene Co's Price-to-Free-Cash-Flow Ratio for today is 78.25.

The historical rank and industry rank for Novogene Co's Price-to-Free-Cash-Flow or its related term are showing as below:

SHSE:688315' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 50.06   Med: 81.03   Max: 133.27
Current: 78.27

During the past 7 years, Novogene Co's highest Price-to-Free-Cash-Flow Ratio was 133.27. The lowest was 50.06. And the median was 81.03.

SHSE:688315's Price-to-Free-Cash-Flow is ranked worse than
77.94% of 204 companies
in the Biotechnology industry
Industry Median: 29.18 vs SHSE:688315: 78.27

Novogene Co's Free Cash Flow per Share for the three months ended in Sep. 2022 was ¥0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥0.37.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Novogene Co was -26.80% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 33.70% per year.

During the past 7 years, Novogene Co's highest 3-Year average Free Cash Flow per Share Growth Rate was 33.70% per year. The lowest was 4.60% per year. And the median was 19.15% per year.


Novogene Co Price-to-Free-Cash-Flow Historical Data

The historical data trend for Novogene Co's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novogene Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Price-to-Free-Cash-Flow
Premium Member Only Premium Member Only - - - - 88.25

Novogene Co Quarterly Data
Dec15 Dec16 Dec17 Jun18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Price-to-Free-Cash-Flow Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 102.13 88.25 110.08 53.91 59.57

Competitive Comparison

For the Biotechnology subindustry, Novogene Co's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Novogene Co Price-to-Free-Cash-Flow Distribution

For the Biotechnology industry and Healthcare sector, Novogene Co's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Novogene Co's Price-to-Free-Cash-Flow falls in comparison to its industry or sector. The grey bar indicates the Price-to-Free-Cash-Flow's extreme value range as defined by GuruFocus.



Novogene Co Price-to-Free-Cash-Flow Calculation

Novogene Co's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=29.11/0.372
=78.25

Novogene Co's Share Price of today is ¥29.11.
Novogene Co's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.37.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Novogene Co  (SHSE:688315) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Novogene Co Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Novogene Co's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Novogene Co (SHSE:688315) Business Description

Novogene Co logo
Traded in Other Exchanges
N/A
Address
No. 29, Shengshengyuan Road, Room B258, Innovation Building, Huilongguan Town, Changping District, Beijing, CHN, 100015
Novogene Co Ltd is engaged in providing multi-level scientific research and technical services and solutions for life science basic research, medical and clinical application research, and independent development and innovation of genetic testing medical equipment.

Novogene Co (SHSE:688315) Headlines

No Headlines